[02199855-CF] CAS 59-05-2 | Methotrexate USP and EP Grade | MP bio
0 ₩
4-Amino-10-methylfolic acid hydrate; L-4-Amino-N10-methylpteroylglutamic acid hydrate; L-Amethopterin hydrate; Antifolan hydrate; MTX hydrate;Methotrexate hydrate; Methylaminopterin hydrate
59-05-2 | 02199855-CF | Methotrexate USP and EP Grade
Key features and details
Methotrexate is a cell cycle arresting agent with varying effects. Methotrexate has been reported to arrest the cell cycle in late G1/S thus leading to the inhibition of the synthesis of DNA, RNA, thymidylates, and proteins. The main mechanism of action is reported to involve the inhibition of enzymes involved in purine metabolism which leads to the accumulation of adenosine or the suppression of intercellular adhesion molecule expression by T cells. Additionally, this compound has been observed to inhibit DHFR.
| SKU | 02199855-CF |
| Alternate Names | 4-Amino-10-methylfolic acid hydrate; L-4-Amino-N10-methylpteroylglutamic acid hydrate; L-Amethopterin hydrate; Antifolan hydrate; MTX hydrate;Methotrexate hydrate; Methylaminopterin hydrate |
| Application Notes | Methotrexate is used for chemotherapy either alone or in combination with other agents. It is effective for the treatment of a number of cancers including: breast, head and neck, leukemia, lymphoma, lung, osteosarcoma, bladder, and trophoblastic neoplasms. It is also used in treatment of autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It is used to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also effective in treatment of pyrimethamine-resistant Plasmodium vivax malaria parasites. |
| Base Catalog Number | 199855 |
| Biochemical Physiological Actions | Methotrexate is an allosteric inhibititor of dihydrofolate reductase (DHFR), the enzyme that catalyzes the conversion of dihydrofolate to tetrahydrofolate. Since tetrahydrolfolate is required for purine and pyrimidine synthesis, methotrexate treatment results in the inhibition of DNA and RNA synthesis. |
| CAS # | 59-05-2 |
| Grade | USP and EP Grade |
| Hazard Statements | H301-H315-H319-H360 |
| Molecular Formula | C20H22N8O5 |
| Molecular Weight | 454.46 |
| Optical Rotation | +19° to +24° (anhydrous basis) |
| Personal Protective Equipment | Eyeshields, Faceshields, full-face particle respirator, Gloves, respirator cartridge, respirator filter |
| RTECS Number | MA1225000 |
| Safety Symbol | GHS06, GHS08 |
| Solubility | Practically insoluble in water, ethanol, chloroform and diethyl ether; freely soluble in dilute solutions of alkaline hydroxides and carbonates; soluble in dilute hydrochloric acid. |
| Usage Statement | Unless specified otherwise, MP Biomedical’s products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
| brand | MP Bio |
|---|---|
| Pakage | 1x100mg, 1x10mg, 1x1g, 1x1mg, 1x25mg, 1x500mg |
